We are live on ! Find out more
DCP

Distillate Capital Partners Portfolio holdings

AUM $1.92B
1-Year Est. Return 5.31%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
-5.31%
3 Year Est. Return
+9.94%
5 Year Est. Return
+39.07%
10 Year Est. Return
AUM
$360M
AUM Growth
+$50.7M
Cap. Flow
+$36.8M
Cap. Flow %
10.23%
Top 10 Hldgs %
19.39%
Holding
144
New
27
Increased
69
Reduced
18
Closed
30

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.79M
2
META icon
Meta Platforms (Facebook)
META
+$7.31M
3
AAPL icon
Apple
AAPL
+$7.12M
4
CMCSA icon
Comcast
CMCSA
+$5.81M
5
CI icon
Cigna
CI
+$4.31M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$5.97M
2
AMAT icon
Applied Materials
AMAT
+$4.41M
3
ELV icon
Elevance Health
ELV
+$3.96M
4
TGT icon
Target
TGT
+$3.27M
5
NSC icon
Norfolk Southern
NSC
+$2.86M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Industrials 18.45%
3 Healthcare 18.24%
4 Consumer Staples 10.02%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$651B
$8M 2.22%
48,533
+5,080
+12% +$841K
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.25T
$7.95M 2.21%
65,140
+1,460
+2% +$171K
META icon
3
Meta Platforms (Facebook)
META
$1.74T
$7.93M 2.21%
+22,800
New +$7.31M
ABBV icon
4
AbbVie
ABBV
$467B
$7.79M 2.17%
+69,152
New +$7.79M
AAPL icon
5
Apple
AAPL
$4.92T
$7.53M 2.09%
+54,953
New +$7.12M
UNH icon
6
UnitedHealth
UNH
$337B
$7.42M 2.06%
18,538
-573
-3% -$228K
CMCSA icon
7
Comcast
CMCSA
$81.3B
$5.92M 1.65%
+103,834
New +$5.81M
HD icon
8
Home Depot
HD
$302B
$5.92M 1.65%
18,558
-1,449
-7% -$461K
PG icon
9
Procter & Gamble
PG
$343B
$5.67M 1.58%
42,031
+1,493
+4% +$202K
CSCO icon
10
Cisco
CSCO
$435B
$5.58M 1.55%
105,283
-10,882
-9% -$572K
ORCL icon
11
Oracle
ORCL
$455B
$5.4M 1.5%
69,332
-2,556
-4% -$200K
PM icon
12
Philip Morris
PM
$297B
$5.11M 1.42%
51,537
+536
+1% +$51.4K
AVGO icon
13
Broadcom
AVGO
$1.66T
$4.95M 1.38%
103,750
-790
-0.8% -$36.6K
INTC icon
14
Intel
INTC
$575B
$4.58M 1.27%
81,572
-32,636
-29% -$1.92M
AMGN icon
15
Amgen
AMGN
$205B
$4.55M 1.27%
18,681
-461
-2% -$113K
BLK icon
16
Blackrock
BLK
$163B
$4.32M 1.2%
4,933
+375
+8% +$317K
TMO icon
17
Thermo Fisher Scientific
TMO
$243B
$4.28M 1.19%
8,486
+958
+13% +$452K
LOW icon
18
Lowe's Companies
LOW
$109B
$4.11M 1.14%
21,175
-1,158
-5% -$227K
CI icon
19
Cigna
CI
$72.9B
$4.09M 1.14%
+17,239
New +$4.31M
ACN icon
20
Accenture
ACN
$116B
$4.08M 1.14%
13,851
+607
+5% +$174K
LMT icon
21
Lockheed Martin
LMT
$124B
$3.97M 1.1%
+10,495
New +$4.04M
TXN icon
22
Texas Instruments
TXN
$236B
$3.89M 1.08%
20,216
+339
+2% +$63.5K
REGN icon
23
Regeneron Pharmaceuticals
REGN
$81.3B
$3.87M 1.08%
6,919
+1,265
+22% +$641K
MMM icon
24
3M
MMM
$84.9B
$3.85M 1.07%
23,158
+325
+1% +$54.2K
BIIB icon
25
Biogen
BIIB
$32.4B
$3.83M 1.06%
11,045
-1,429
-11% -$433K

Similar funds

Distillate Capital Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Distillate Capital Partners held 144 positions worth $360M, up 16% from $309M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Distillate Capital Partners deployed $36.8M of net new capital in Q2 2021, opening 27 new positions and adding to 69 existing holdings. Its largest new stake was AbbVie: 69,152 shares worth $7.79M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Intel, an estimated $1.92M trimmed.

  • Distillate Capital Partners's largest Q2 2021 buy was AbbVie: 69,152 shares worth $7.79M.
  • Distillate Capital Partners added most to Johnson & Johnson in Q2 2021, an estimated $841K increase.
  • Distillate Capital Partners's biggest Q2 2021 reduction was Intel, cutting an estimated $1.92M.
  • Distillate Capital Partners fully exited Walmart Inc in Q2 2021, selling an estimated $5.97M.
  • Distillate Capital Partners's ten largest holdings make up 19% of its $360M portfolio in Q2 2021.
  • Distillate Capital Partners opened 27 new positions and closed 30 in Q2 2021.
  • Distillate Capital Partners's portfolio value rose 16% quarter-over-quarter to $360M.

Based on Distillate Capital Partners's 13F filing for Q2 2021, filed 30 Jul 2021.